14th Annual Outsourcing in Clinical Trials Southern California 2026
UBC partners with biopharma sponsors to deliver evidence development solutions that are expert-led, technology-enabled, and purpose-built for specialty therapies. From early-stage study design through post-market research, our team helps you generate the real-world evidence needed to support regulatory submissions, demonstrate long-term product value, and meet the evolving expectations of patients, payers, and providers.
- Modernized Study Design & Execution: Fit-for-purpose study designs that reduce operational burden, improve enrollment, and accelerate the path to meaningful data.
- Integrated Evidence Generation Strategy: Comprehensive planning that aligns clinical and real-world evidence strategies with your regulatory and commercial objectives.
- Late-Stage Research: Post-approval observational studies, registries, and pragmatic trials that extend the evidence base and support ongoing market access.
- Real-World Evidence: Scalable approaches to capturing and analyzing real-world data that inform stakeholder decision-making throughout the product lifecycle.
Connect with UBC at OCT SoCal 2026 to learn how our evidence development solutions can strengthen your clinical program and generate the insights that drive better patient outcomes.
Schedule a Meeting
Learn More About UBC
We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.
Other Events
World Patient Safety Congress Americas 2026
World Patient Safety Congress Europe 2026
DPHARM 2026
Schedule a Meeting
Thank You for Connecting with UBC
.
What You Can Expect Next
.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.